HSITF (Hadasit Bio Holdings) EBITDA Margin %: 0.00% (As of Dec. 2025)


HSITF Hadasit Bio Holdings Ltd HSITF
14 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Hadasit Bio Holdings EBITDA Margin %?

Hadasit Bio Holdings HSITF 14 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates HSITF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 945 Biotechnology companies, Hadasit Bio Holdings ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hadasit Bio Holdings's EBITDA for the six months ended in Dec. 2025 was $-0.25 Mil. Hadasit Bio Holdings's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Hadasit Bio Holdings's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Hadasit Bio Holdings  (OTCPK:HSITF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Hadasit Bio Holdings EBITDA Margin % Related Terms

Hadasit Bio Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Hadasit Bio Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hadasit Bio Holdings EBITDA Margin % Chart

Hadasit Bio Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hadasit Bio Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,179.17 -2,669.70 1,400.00 0.00 0.00

HSITF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Hadasit Bio Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hadasit Bio Holdings EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hadasit Bio Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hadasit Bio Holdings's EBITDA Margin % falls into.


HSITF
14GF Score
Hadasit Bio Holdings Ltd HSITF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hadasit Bio Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hadasit Bio Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.572/0
= %

Hadasit Bio Holdings's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.247/-0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Hadasit Bio Holdings (HSITF) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hadasit Bio Holdings and its competitors. According to the industry distribution chart, Hadasit Bio Holdings ranks #999999 out of 945 companies in the Biotechnology industry.
Is Hadasit Bio Holdings' EBITDA Margin % too high?
Hadasit Bio Holdings' current EBITDA Margin % is 0.00%. Based on the distribution chart, Hadasit Bio Holdings ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hadasit Bio Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Hadasit Bio Holdings' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hadasit Bio Holdings ranks #999999 out of 945 companies for EBITDA Margin %. This places Hadasit Bio Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hadasit Bio Holdings and its competitors. Hadasit Bio Holdings's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hadasit Bio Holdings stock overvalued right now?
Hadasit Bio Holdings (HSITF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Hadasit Bio Holdings' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hadasit Bio Holdings (HSITF), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hadasit Bio Holdings Business Description

Other Exchanges HDST-M:Israel
Address 5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.
14GF Score

Get the complete analysis for HSITF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price